Home › Funds › Geode Capital Management › CCEL
Geode Capital Management position in CCEL
CRYO-CELL INTL INC · Health Care
Latest position (Q2 2026)46.27K sh
Reported value held$147.65K
Portfolio Weight0.00%
First reportedQ3 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2022 | 19.16K | $116.00K | New |
| Q4 2022 | 19.08K | $80 | Hold |
| Q1 2023 | 19.08K | $57.63K | Hold |
| Q2 2023 | 19.08K | $116.02K | Hold |
| Q3 2023 | 20.95K | $110.27K | Add |
| Q4 2023 | 20.95K | $120.53K | Hold |
| Q1 2024 | 21.43K | $159.93K | Add |
| Q2 2024 | 23.66K | $180.12K | Add |
| Q3 2024 | 39.86K | $253.98K | Add |
| Q4 2024 | 39.86K | $295.46K | Hold |
| Q1 2025 | 45.23K | $288.20K | Add |
| Q2 2025 | 45.83K | $237.92K | Add |
| Q3 2025 | 53.42K | $247.91K | Add |
| Q4 2025 | 53.17K | $182.94K | Hold |
| Q1 2026 | 43.62K | $154.88K | Reduce |
| Q2 2026 | 46.27K | $147.65K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CCEL
- Vanguard Group 150.99K sh · $519.41K · Q4 2025
- Fidelity Management & Research (FMR) 20.00K sh · $63.80K · Q2 2026
- BlackRock Inc 6.70K sh · $21.36K · Q2 2026
- Morgan Stanley 605 sh · $1.93K · Q2 2026
- UBS Group AG 316 sh · $1.01K · Q2 2026